Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1973;5:68–71. doi: 10.1136/jcp.s1-5.1.68

Secondary hyperlipidaemia.

A Chait
PMCID: PMC1436099  PMID: 4582172

Full text

PDF
68

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTONIS A., BERSOHN I. The influence of diet on serumtriglycerides in South Africa white and Bantu prisoners. Lancet. 1961 Jan 7;1(7167):3–9. doi: 10.1016/s0140-6736(61)92180-8. [DOI] [PubMed] [Google Scholar]
  2. BIERMAN E. L., DOLE V. P., ROBERTS T. N. An abnormality of nonesterified fatty acid metabolism in diabetes mellitus. Diabetes. 1957 Nov-Dec;6(6):475–479. doi: 10.2337/diab.6.6.475. [DOI] [PubMed] [Google Scholar]
  3. Bagdade J. D., Porte D., Jr, Bierman E. L. Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med. 1967 Feb 23;276(8):427–433. doi: 10.1056/NEJM196702232760802. [DOI] [PubMed] [Google Scholar]
  4. Bagdade J. D., Porte D., Jr, Bierman E. L. Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med. 1968 Jul 25;279(4):181–185. doi: 10.1056/NEJM196807252790403. [DOI] [PubMed] [Google Scholar]
  5. Basso L. V., Havel R. J. Hepatic metabolism of free fatty acids in normal and diabetic dogs. J Clin Invest. 1970 Mar;49(3):537–547. doi: 10.1172/JCI106264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bastenie P. A., Vanhaelst L., Bonnyns M., Neve P., Staquet M. Preclinical hypothyroidism: a risk factor for coronary heart-disease. Lancet. 1971 Jan 30;1(7692):203–204. doi: 10.1016/s0140-6736(71)90947-0. [DOI] [PubMed] [Google Scholar]
  7. Bluestone R., Lewis B., Mervart I. Hyperlipoproteinaemia in gout. Ann Rheum Dis. 1971 Mar;30(2):134–137. doi: 10.1136/ard.30.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boberg J., Carlson L. A., Hallberg D. Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man. J Atheroscler Res. 1969 Mar-Apr;9(2):159–169. doi: 10.1016/s0368-1319(69)80051-7. [DOI] [PubMed] [Google Scholar]
  9. Boyer J. L., Scheig R. L. Inhibition of postheparin lipolytic activity in uremia and its relationship to hypertriglyceridemia. Proc Soc Exp Biol Med. 1970 Jul;134(3):603–605. doi: 10.3181/00379727-134-34842. [DOI] [PubMed] [Google Scholar]
  10. Brons M., Christensen N. C., Horder M. Hyperlipoproteinemia in patients with chronic renal failure. Acta Med Scand. 1972 Jul-Aug;192(1-2):119–123. doi: 10.1111/j.0954-6820.1972.tb04787.x. [DOI] [PubMed] [Google Scholar]
  11. Chait A., Mancini M., February A. W., Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet. 1972 Jul 8;2(7767):62–64. doi: 10.1016/s0140-6736(72)91552-8. [DOI] [PubMed] [Google Scholar]
  12. Chance G. W., Albutt E. C., Edkins S. M. Serum lipids and lipoproteins in untreated diabetic children. Lancet. 1969 Jun 7;1(7606):1126–1128. doi: 10.1016/s0140-6736(69)91645-6. [DOI] [PubMed] [Google Scholar]
  13. Elkeles R. S., Lowy C., Wyllie A. D., Young J. L., Fraser T. R. Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet. 1971 May 1;1(7705):880–883. doi: 10.1016/s0140-6736(71)92442-1. [DOI] [PubMed] [Google Scholar]
  14. Fowler P. B., Swale J., Andrews H. Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet. 1970 Sep 5;2(7671):488–491. doi: 10.1016/s0140-6736(70)90111-x. [DOI] [PubMed] [Google Scholar]
  15. Glueck C. J., Levy R. I., Fredrickson D. S. Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia. Diabetes. 1969 Nov;18(11):739–747. doi: 10.2337/diab.18.11.739. [DOI] [PubMed] [Google Scholar]
  16. HOLLENBERG C. H. Effect of nutrition on activity and release of lipase from rat adipose tissue. Am J Physiol. 1959 Sep;197:667–670. doi: 10.1152/ajplegacy.1959.197.3.667. [DOI] [PubMed] [Google Scholar]
  17. Hayes T. M. Plasma lipoproteins in adult diabetes. Clin Endocrinol (Oxf) 1972 Jul;1(3):247–251. doi: 10.1111/j.1365-2265.1972.tb00395.x. [DOI] [PubMed] [Google Scholar]
  18. Hazzard W. R., Spiger M. J., Bagdade J. D., Bierman E. L. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med. 1969 Feb 27;280(9):471–474. doi: 10.1056/NEJM196902272800904. [DOI] [PubMed] [Google Scholar]
  19. Kekki M., Nikkilä E. A. Plasma triglyceride turnover during use of oral contraceptives. Metabolism. 1971 Sep;20(9):878–889. doi: 10.1016/0026-0495(71)90050-3. [DOI] [PubMed] [Google Scholar]
  20. LIEBER C. S., DAVIDSON C. S. Some metabolic effects of ethyl alcohol. Am J Med. 1962 Sep;33:319–327. doi: 10.1016/0002-9343(62)90229-2. [DOI] [PubMed] [Google Scholar]
  21. LIEBER C. S., SCHMID R. The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest. 1961 Feb;40:394–399. doi: 10.1172/JCI104266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lewis B., Boberg L., Mancini M., Carlson L. A. Determination of the intravenous fat tolerance test with intralipid by nephelometry. Atherosclerosis. 1972 Jan-Feb;15(1):83–86. doi: 10.1016/0021-9150(72)90040-8. [DOI] [PubMed] [Google Scholar]
  23. Lewis B., Mancini M., Mattock M., Chait A., Fraser T. R. Plasma triglyceride and fatty acid metabolism in diabetes mellitus. Eur J Clin Invest. 1972 Nov;2(6):445–453. doi: 10.1111/j.1365-2362.1972.tb00676.x. [DOI] [PubMed] [Google Scholar]
  24. Losowsky M. S., Kenward D. H. Lipid metabolism in acute and chronic renal failure. J Lab Clin Med. 1968 May;71(5):736–743. [PubMed] [Google Scholar]
  25. RUSS E. M., RAYMUNT J., BARR D. P. Lipoproteins in primary biliary cirrhosis. J Clin Invest. 1956 Feb;35(2):133–144. doi: 10.1172/JCI103257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rössner S., Larsson-Cohn U., Carlson L. A., Boberg J. Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. Acta Med Scand. 1971 Oct;190(4):301–305. doi: 10.1111/j.0954-6820.1971.tb07435.x. [DOI] [PubMed] [Google Scholar]
  27. Seidel D., Alaupovic P., Furman R. H. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest. 1969 Jul;48(7):1211–1223. doi: 10.1172/JCI106085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stokes T., Wynn V. Serum-lipids in women on oral contraceptives. Lancet. 1971 Sep 25;2(7726):677–680. doi: 10.1016/s0140-6736(71)92247-1. [DOI] [PubMed] [Google Scholar]
  29. Tulloch B. R., Vydelingum N., Lewis B., Fraser R. Triglyceride metabolism in thyroid disease. Clin Sci. 1973 Feb;44(2):6P–passim. doi: 10.1042/cs044006p. [DOI] [PubMed] [Google Scholar]
  30. Van Harken D. R., Brown T. O., Heimberg M. Hepatic lipid metabolism in experimental diabetes: III. Synthesis and utilization of triglycerides. Lipids. 1967 May;2(3):231–238. doi: 10.1007/BF02532561. [DOI] [PubMed] [Google Scholar]
  31. ZIEVE L. Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis. Ann Intern Med. 1958 Mar;48(3):471–496. doi: 10.7326/0003-4819-48-3-471. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES